Published :
Tables : 54
Figures : 45
Category : Healthcare
No. of Pages : 215
Report Code : HC-U3405
Multiplex Detection Immunoassays Market is poised to value USD 3158.46 million by 2028 end at a CAGR of 7.5% during the forecast period 2022 to 2028. The wide range of applications of superior detection immunoassays over conventional detection assays based on linear maintenance for many orders has been the primary factor responsible for the multiplex detection immunoassays market growth. Furthermore, the rising prevalence of chronic disorders like Alzheimer’s and cancer along with the creation of simultaneous, time-saving and cost-effective measurement of different analytes in one sample. Multiplex detection assays are suited for diagnosing autoimmune and heterogeneous diseases. In addition, these assays are utilised for identifying and measuring analytes like inflammatory proteins, kinase, growth factors and cytokine in animals. Such factors shall bolster the proliferation of the market. Multiplex Detection Immunoassays Market Segmentation: By Assay Type • Planar Assays • Bead-Based Assays By Technique • Nuclei Acid Based Technique • Protein Based Technique • Biosensor Based Technique By Application • Disease Testing • Food Contamination Testing • Research and Development • Veterinary Disease Testing By End User • Pharmaceutical Companies • Clinical Research Organizations • Food & Beverages Companies • Academic Research Institutes • Diagnostic Centers • Biotechnology Centers By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa The market is categorised into assay type, technique, application, end user and region. The assay type segment is fragmented into planar assay and bead-based assay. The planar assay segment is sub-segmented into blends protein arrays and antibody arrays while the bead-based assay segment is divided into magnetic bead-based assay and non-magnetic bead-based assay. The technique segment is diversified into nuclei acid-based technique, protein-based technique and biosensor-based technique. The application segment is bifurcated into disease testing, food contamination testing, research and development and veterinary disease testing. The end user segment is segmented into pharmaceutical companies, clinical research organizations, food & beverage companies, academic research institutes, diagnostic centres and biotech centres. Regional Analysis: The North America region is predicted to hold the largest multiplex detection immunoassays market share owing to advancements in immunoassay technology, increased disposable income of general population and a strong presence of major market players in the region. Furthermore, rise in the number of diagnostic centres shall boost the market growth substantially. Competitive Landscape: Some of the prominent market players are F. Hoffmann-La Roche AG, QIAGEN N.V, EMD Millipore, Microsynh AG., Bio-Rad, Thermo Fisher Scientific Inc., Luminex Corporation, BD Biosciences. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global multiplex detection immunoassays market by assay type, by technique, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The wide range of applications of superior detection immunoassays over conventional detection assays based on linear maintenance for many orders has been the primary factor responsible for the multiplex detection immunoassays market growth. Furthermore, the rising prevalence of chronic disorders like Alzheimer’s and cancer along with the creation of simultaneous, time-saving and cost-effective measurement of different analytes in one sample. Multiplex detection assays are suited for diagnosing autoimmune and heterogeneous diseases. In addition, these assays are utilised for identifying and measuring analytes like inflammatory proteins, kinase, growth factors and cytokine in animals. Such factors shall bolster the proliferation of the market.
Multiplex Detection Immunoassays Market Segmentation: By Assay Type • Planar Assays • Bead-Based Assays By Technique • Nuclei Acid Based Technique • Protein Based Technique • Biosensor Based Technique By Application • Disease Testing • Food Contamination Testing • Research and Development • Veterinary Disease Testing By End User • Pharmaceutical Companies • Clinical Research Organizations • Food & Beverages Companies • Academic Research Institutes • Diagnostic Centers • Biotechnology Centers By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
The market is categorised into assay type, technique, application, end user and region. The assay type segment is fragmented into planar assay and bead-based assay. The planar assay segment is sub-segmented into blends protein arrays and antibody arrays while the bead-based assay segment is divided into magnetic bead-based assay and non-magnetic bead-based assay. The technique segment is diversified into nuclei acid-based technique, protein-based technique and biosensor-based technique. The application segment is bifurcated into disease testing, food contamination testing, research and development and veterinary disease testing. The end user segment is segmented into pharmaceutical companies, clinical research organizations, food & beverage companies, academic research institutes, diagnostic centres and biotech centres.
Regional Analysis: The North America region is predicted to hold the largest multiplex detection immunoassays market share owing to advancements in immunoassay technology, increased disposable income of general population and a strong presence of major market players in the region. Furthermore, rise in the number of diagnostic centres shall boost the market growth substantially.
Competitive Landscape: Some of the prominent market players are F. Hoffmann-La Roche AG, QIAGEN N.V, EMD Millipore, Microsynh AG., Bio-Rad, Thermo Fisher Scientific Inc., Luminex Corporation, BD Biosciences.
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global multiplex detection immunoassays market by assay type, by technique, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Multiplex Detection Immunoassays Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Multiplex Detection Immunoassays Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Multiplex Detection Immunoassays Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Multiplex Detection Immunoassays Market, By Assay Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1 Planar Assays 7.2 Bead-Based Assays 8. Multiplex Detection Immunoassays Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 8.1 Nuclei Acid Based Technique 8.2 Protein Based Technique 8.3 Biosensor Based Technique 9. Multiplex Detection Immunoassays Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1 Disease Testing 9.2 Food Contamination Testing 9.3 Research and Development 9.4 Veterinary Disease Testing 10. Multiplex Detection Immunoassays Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1 Pharmaceutical Companies 10.2 Clinical Research Organizations 10.3 Food & Beverages Companies 10.4 Academic Research Institutes 10.5 Diagnostic Centers 10.6 Biotechnology Centers 11. North America Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. F. Hoffmann-La Roche AG 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. QIAGEN N.V 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. EMD Millipore 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Microsynh AG. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Bio-Rad 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Thermo Fisher Scientific Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Luminex Corporation 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. BD Biosciences 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Multiplex Detection Immunoassays Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Multiplex Detection Immunoassays Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Multiplex Detection Immunoassays Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Multiplex Detection Immunoassays Market, By Assay Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1 Planar Assays 7.2 Bead-Based Assays
8. Multiplex Detection Immunoassays Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 8.1 Nuclei Acid Based Technique 8.2 Protein Based Technique 8.3 Biosensor Based Technique
9. Multiplex Detection Immunoassays Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1 Disease Testing 9.2 Food Contamination Testing 9.3 Research and Development 9.4 Veterinary Disease Testing
10. Multiplex Detection Immunoassays Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1 Pharmaceutical Companies 10.2 Clinical Research Organizations 10.3 Food & Beverages Companies 10.4 Academic Research Institutes 10.5 Diagnostic Centers 10.6 Biotechnology Centers
11. North America Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Multiplex Detection Immunoassays Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. F. Hoffmann-La Roche AG 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. QIAGEN N.V 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. EMD Millipore 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Microsynh AG. 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Bio-Rad 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Thermo Fisher Scientific Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Luminex Corporation 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. BD Biosciences 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics